Delivery Order SPE2DE21D0005-SPE2D626F84WW
Award Date 3/3/26
Potential Completion Date 3/9/26
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,118.88 fixed-price delivery order to Organogenesis Inc. for PURAPLY AM (2X2) 4 SQ CM wound care dressing, with an ultimate completion date of September 29, 2025. The contract was awarded on September 23, 2025, without set-aside designation, allowing Organogenesis to compete as a standard commercial vendor. The place of performance is the company's headquarters in Canton, Massachusetts. PURAPLY AM is an advanced...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,504.00 to Organogenesis Inc. for PURAPLY Micronized, 500mg on October 29, 2025. This delivery order, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by November 3, 2025, and will be performed at the company's headquarters in Canton, Massachusetts. The contract represents a continuation of Organogenesis's ongoing supply of advanced wound care and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
- This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,504.00 contract is for the supply of PURAPLY MICRONIZED, 500MG, a specialized medical product used for advanced wound care. The award has an ultimate completion date of July 21, 2025. Organogenesis is a for-profit manufacturer that holds several significant federal Indefinite Delivery Vehicles (IDVs)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products headquartered in Canton, Massachusetts. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment and has a period of performance through March 6, 2025. This award is not associated with a set-aside designation,...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $2,088.00 for PURAPLY Micronized, 500mg on July 31, 2025, with an ultimate completion date of August 5, 2025. This fixed-price contract with economic price adjustment was awarded without set-aside designation by the Defense Logistics Agency's Medical Supply Chain division. PURAPLY Micronized is an advanced wound care product utilized in regenerative medicine...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a $8,500 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain division on May 30, 2025. The delivery order, with an ultimate completion date of June 4, 2025, covers PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. This award was made without a set-aside designation, indicating that Organogenesis competed as a standard...
- Organogenesis Inc. was awarded a $8,500 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by July 28, 2025. The work will be performed at Organogenesis' headquarters in Canton, Massachusetts. No set-aside designation was utilized for this award, indicating...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a fixed-price delivery order contract with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company, to provide PURAPLY AM (2x2) 4 sq cm wound care dressings. The $1,678.32 contract has a completion date of January 10, 2024. Organogenesis Inc. has previously provided surgical implants, wound care dressings and matrices, tissue regeneration products, and other medical supplies to federal agencies...
- The Defense Logistics Agency Troop Support Medical awarded a $4,437.76 fixed-price delivery order with economic price adjustment to Organogenesis Inc. for PURAPLY AM (2X2) 4 square centimeter dressings. Organogenesis Inc. will deliver the medical dressings from its Canton, Massachusetts division between April 26 and May 2, 2023. The Defense Logistics Agency supports Department of Defense health care programs by procuring medical supplies and equipment. This delivery order was issued against an...
- SPE2DE21D0005Indefinite Delivery Contract
- SPE2DE21D0005-SPE2D626F84WWDelivery Order
The Defense Logistics Agency Medical Supply Chain issued a delivery order to Organogenesis Inc. on March 3, 2026, with a ceiling value of $1,600 for PURAPLY AM (2×2) 4 sq cm wound care products, under a total small business set-aside. Place of performance is Canton, MA. The order is fixed price with economic price adjustment and is due for completion by March 9, 2026. Organogenesis is a regenerative medicine company specializing in advanced wound care and tissue regeneration products for federal healthcare agencies, including the VA and DLA.
Generated 6/1/26, 10:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/2/26 |